Press Releases
GlaxoSmithKline
-
Genesis Biopharma Names Biotech Industry Veteran Hans E. Bishop as Executive Chairman of the Board
Genesis Biopharma Names Biotech Industry Veteran Hans E. Bishop as Executive Chairman of the Board PR Newswire LOS ANGELES , March 22, 2012 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC/BB: GNBP), a biotechnology company developing...
-
Global Medical Devices Survey 2012--2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry
Global Medical Devices Survey 2012--2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry PR Newswire NEW YORK , March 21, 2012 /PRNewswire/ -- Reportlinker.com announces that...
-
JacksonWhite Files Overtime Lawsuit Against Sunovion Pharmaceuticals
JacksonWhite Files Overtime Lawsuit Against Sunovion Pharmaceuticals Virtually All Major Drug Companies Now Face Class or Collective Action Suits for Violating Federal and State Labor Laws PR Newswire MESA, Ariz. , March 16, 2012...
-
Healthcare Executive Francesco Granata Joins Warburg Pincus as Executive-in-Residence
Healthcare Executive Francesco Granata Joins Warburg Pincus as Executive-in-Residence PR Newswire LONDON and NEW YORK , March 5, 2012 /PRNewswire/ -- Warburg Pincus, a leading global private equity firm focused on growth investing,...
-
Healthcare Executive Francesco Granata Joins Warburg Pincus as Executive-in-Residence
Healthcare Executive Francesco Granata Joins Warburg Pincus as Executive-in-Residence PR Newswire LONDON and NEW YORK , March 5, 2012 /PRNewswire/ -- Warburg Pincus, a leading global private equity firm focused on growth investing,...
-
NicOx 2011 Financial Results
SOPHIA ANTIPOLIS, FRANCE -- (Marketwire) -- 02/29/12 -- PRESS RELEASE NicOx 2011 Financial Results Sophia Antipolis, France. www.nicox.com NicOx S.A. (NYSE Euronext Paris: COX) today announces its financial results for the year...
-
CNJ Enterprises: DePuy ASR Hip Implant Recall Large Contributor to Johnson & Johnson's $2.9 Bil Charge for 4th Quarter 2011
CNJ Enterprises: DePuy ASR Hip Implant Recall Large Contributor to Johnson & Johnson's $2.9 Bil Charge for 4th Quarter 2011 -CEO Bill Weldon to step down as DePuy recall could top $3bil PR Newswire NEW YORK...
-
Arch Biopartners Appoints Claude Allary as Special Advisor
Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) announced today Claude Allary has been appointed Special Advisor to the Company. In this capacity, Mr. Allary will provide expertise in evaluating commercial opportunities...
-
Sirona Biochem Appoints Sean Cunliffe to Chief Business Officer and Board of Directors
Editors note: There is a photo associated with this press release. Sirona Biochem Corp. (TSX VENTURE:SBM)(PINKSHEETS:SRBCF)(FRANKFURT:ZSB) (the "Company"), a biotechnology company specializing in carbohydrate chemistry technology, announced...
-
Barchester Green Investment's Annual "Heroes and Villains" of ethical & environmental funds 2011
Dec 14, 2011 (PRN) : Barchester Green Investment| http://www.barchestergreen.co.uk , the UK’s leading independent financial adviser specialising in ethical and environmental investment, has announced its Heroes and Villains of 2011. Barchester’s...
-
Stem Cell Therapeutics Announces Reorganization and Management Changes
New Commercial Focus on Licensing and Acquisition of Additional Stem Cell Technologies Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) today announced a corporate reorganization to reposition the company as the commercialization partner...
-
Horizon Pharma Adds Two New Biopharmaceutical Executives to Its Board of Directors
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced the appointments of Michael Grey and Ronald Pauli to the Company's Board of Directors. "We are pleased to welcome Mike and Ron to our board. Their extensive pharma and biopharmaceutical experience...
-
GlaxoSmithKline and Amicus Therapeutics commence second phase III study of Amigal™ for Fabry disease
Issued: Monday 12 September 2011, London UK and Cranbury, New Jersey, US GlaxoSmithKline (GSK) and Amicus Therapeutics today announced the first patient has commenced dosing in a Phase III global registration study (Study 012) to compare...
-
Cornerstone Therapeutics Appoints New President
Cornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on developing, acquiring and commercializing products for the respiratory, hospital and related specialty markets, today announced the appointment of Kenneth...
-
CZ BioMed Corp. Names Internationally Renowned Dr. Ronald E. Wheeler, M.D. as Medical Director of Its Scientific and Medical Advisory Boards
CZ BioMed Corp. -- Research for Cancer Cure -- RVLYSIN(R) CZ BioMed Corp., a leading company in the field of oncolytic virotherapy, providing research, development, commercialization and treatments, pursuant to the eradication of various...
Follow us
What people say
Our Partners
© 2005-2012